Thomaspartners Inc. increased its stake in Walgreens Boots Alliance Inc. (NASDAQ:WBA) by 0.4% during the second quarter, Holdings Channel reports. The institutional investor owned 4,337 shares of the pharmacy operator’s stock after buying an additional 18 shares during the period. Thomaspartners Inc.’s holdings in Walgreens Boots Alliance were worth $361,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently modified their holdings of the company. State Street Corp increased its position in shares of Walgreens Boots Alliance by 2.1% in the first quarter. State Street Corp now owns 36,198,072 shares of the pharmacy operator’s stock valued at $3,049,327,000 after buying an additional 746,698 shares in the last quarter. Wellington Management Group LLP increased its stake in shares of Walgreens Boots Alliance by 9.7% in the first quarter. Wellington Management Group LLP now owns 26,167,061 shares of the pharmacy operator’s stock worth $2,204,313,000 after buying an additional 2,317,093 shares during the period. Bank of New York Mellon Corp increased its stake in shares of Walgreens Boots Alliance by 7.2% in the second quarter. Bank of New York Mellon Corp now owns 13,003,529 shares of the pharmacy operator’s stock worth $1,082,804,000 after buying an additional 874,011 shares during the period. Geode Capital Management LLC increased its stake in shares of Walgreens Boots Alliance by 3.0% in the first quarter. Geode Capital Management LLC now owns 7,602,662 shares of the pharmacy operator’s stock worth $639,250,000 after buying an additional 223,243 shares during the period. Finally, Canada Pension Plan Investment Board increased its stake in shares of Walgreens Boots Alliance by 602.0% in the first quarter. Canada Pension Plan Investment Board now owns 6,665,630 shares of the pharmacy operator’s stock worth $561,513,000 after buying an additional 5,716,161 shares during the period. Institutional investors and hedge funds own 59.74% of the company’s stock.

Shares of Walgreens Boots Alliance Inc. (NASDAQ:WBA) traded down 0.05% on Friday, hitting $82.34. The stock had a trading volume of 522,702 shares. Walgreens Boots Alliance Inc. has a 12 month low of $71.50 and a 12 month high of $95.74. The company’s 50 day moving average price is $81.79 and its 200-day moving average price is $81.27. The company has a market cap of $89.12 billion, a P/E ratio of 28.45 and a beta of 1.01.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Wednesday, July 6th. The pharmacy operator reported $1.18 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.14 by $0.04. Walgreens Boots Alliance had a return on equity of 15.56% and a net margin of 2.70%. The firm earned $29.50 billion during the quarter. During the same period in the prior year, the business posted $1.02 earnings per share. Walgreens Boots Alliance’s revenue was up 2.4% on a year-over-year basis. On average, analysts expect that Walgreens Boots Alliance Inc. will post $4.51 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Monday, September 12th. Investors of record on Friday, August 19th were paid a dividend of $0.375 per share. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.36. This represents a $1.50 dividend on an annualized basis and a dividend yield of 1.82%. The ex-dividend date was Wednesday, August 17th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is currently 51.90%.

A number of brokerages have recently issued reports on WBA. Robert W. Baird reiterated an “outperform” rating and set a $98.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, June 27th. Evercore ISI reiterated a “buy” rating and set a $93.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, July 7th. Zacks Investment Research upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Tuesday, June 21st. Credit Suisse Group AG reiterated an “outperform” rating and set a $95.00 price target (up previously from $80.71) on shares of Walgreens Boots Alliance in a research report on Thursday, September 1st. Finally, Deutsche Bank AG reiterated a “buy” rating on shares of Walgreens Boots Alliance in a research report on Monday, July 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the company. Walgreens Boots Alliance presently has an average rating of “Buy” and an average target price of $93.13.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,067 shares of the firm’s stock in a transaction on Tuesday, July 26th. The stock was sold at an average price of $81.35, for a total transaction of $168,150.45. Following the transaction, the director now directly owns 26,690 shares in the company, valued at approximately $2,171,231.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Kathleen Wilson-Thompson sold 29,695 shares of the firm’s stock in a transaction on Thursday, July 14th. The stock was sold at an average price of $83.00, for a total value of $2,464,685.00. The disclosure for this sale can be found here. Corporate insiders own 21.10% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

5 Day Chart for NASDAQ:WBA

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc. (NASDAQ:WBA).

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.